Related Experiment Video
Updated: Apr 4, 2026

Isolation of Viral Replication Compartment-enriched Sub-nuclear Fractions from Adenovirus-infected Normal Human Cells
Published on: November 12, 2015
Enhancing Oncolytic Adenovirus Replication by Early Region 1A Protein-Mediated Degradation of E1A Binding Protein
Boduan Xiao1, Qingzhe Yang1, Shichuan Hu1
1Department of Biotherapy,Cancer Center and State Key Laboratory of Biotherapy West China Hospital Sichuan University Chengdu People's Republic of China.
Abstract:
Oncolytic adenovirus (OAd) therapy is one of the effective treatment strategies for solid malignant tumors, and E1A is a requirement for adenovirus replication. Thus, it is very important to study how E1A regulates adenovirus replication. The p300 and E1A expression were detected by Western blot. The viral replication of OAd was detected by virus replication assay. The interaction between E1A and p300 was analyzed by immunofluorescence and immunoprecipitation assays. The therapeutic effect of OAd-shp300 was analyzed by MTT assay and animal experiments. The results indicated that OAd infection or E1A overexpression could reduce p300 expression, implying that OAd might reduce p300 expression via E1A, and p300 knockdown could enhance viral replication and cell cytotoxicity of OAd. Furthermore, E1A promoted viral replication of OAd via mediating p300 ubiquitination degradation to inhibit the IFI16/STING/IRF3/IFN-β signaling pathway. Additionally, OAd-shp300 induced highly efficient viral replication and potent antitumor activity both in vitro and in vivo. In this study, OAd can reduce p300 expression by promoting its ubiquitination via E1A, thereby enhancing viral replication and cell cytotoxicity. Therefore, this study can provide a biomarker for screening patients who are sensitive to OAd and new ideas for clinical tumor treatment.
Insights
Oncolytic adenovirus (OAd) therapy uses E1A to reduce p300 expression, enhancing viral replication and tumor cell killing. This mechanism offers a potential biomarker for OAd patient selection and novel cancer treatment strategies.
Area of Science:
- Oncolytic virotherapy
- Molecular oncology
- Cancer immunology
Background:
- Oncolytic adenovirus (OAd) is a promising cancer treatment, relying on viral replication.
- Adenovirus E1A protein is crucial for viral replication.
- Understanding E1A's regulatory role in OAd replication is vital for optimizing therapy.
Purpose of the Study:
- To investigate the mechanism by which E1A regulates OAd replication.
- To explore the interaction between E1A and the p300 protein.
- To evaluate the therapeutic potential of enhancing OAd activity through p300 modulation.
Main Methods:
- Western blot to detect p300 and E1A expression.
- Virus replication assays to quantify OAd replication.
- Immunofluorescence and immunoprecipitation to analyze E1A-p300 interaction.
- MTT assays and animal experiments to assess therapeutic efficacy.
Main Results:
- OAd infection or E1A overexpression reduced p300 expression.
- p300 knockdown enhanced OAd viral replication and cancer cell cytotoxicity.
- E1A promoted OAd replication by mediating p300 ubiquitination and inhibiting the IFI16/STING/IRF3/IFN-β pathway.
- OAd engineered to knockdown p300 (OAd-shp300) showed enhanced replication and potent antitumor activity in vitro and in vivo.
Conclusions:
- OAd utilizes E1A to promote p300 ubiquitination and degradation, enhancing viral replication and cytotoxicity.
- This mechanism provides a potential biomarker for identifying patients responsive to OAd therapy.
- Targeting p300 offers a novel strategy for improving clinical outcomes in OAd cancer treatment.
More Related Videos
04:29Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA
Published on: November 1, 2024
11:00Adenovirus-mediated Genetic Removal of Signaling Molecules in Cultured Primary Mouse Embryonic Fibroblasts
Published on: September 9, 2010
Related Concept Videos
Anaphase Promoting Complex
Leaky Scanning
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
GPCRs Regulate Adenylyl Cylase Activity
Viral Replication: Lytic Cycle